Ventricular Assist Devices Market Share, Size, Trends and Forecasts 2016-2020
- Submitted by: Marketreport
- Views: 58
- Category: Other
- Date Submitted: 09/16/2016 12:58 AM
- Pages: 3
- Report this Essay
Technavio Announces the Publication of its Research Report Global Ventricular Assist Devices (VADs) Market 2016-2020
Technavio recognizes the following companies as the key players in the global ventricular assist devices (VADs) market: ABIOMED, Berlin Heart, HeartWare, and St. Jude Medical.
Other Prominent Vendors in the market are: CardiacAssist Technologies, CORWAVE, EVAHEART, Jarvik Heart, Leviticus Cardio, ReliantHeart, Sunshine Heart, and Ventracor.
Browse full report with TOC@ https://marketreportscenter.com/reports/383352/global-ventricular-assist-devices-market-2016-2020
Commenting on the report, an analyst from Technavios team said: Focusing on evidence-based research will be a key trend for market growth. Vendors are collaborating with researchers, academics, and research institutes to obtain sufficient clinical evidence data for the approval and commercialization of their products. Vendors also initiate clinical trials and research activities of their pipeline products to obtain their efficacy and safety profile. For instance, Thoratec is enrolling people for the HeartMate III US clinical trial. In December 2014, the company enrolled 50 individuals under the HeartMate III CE Mark trial at 10 sites across Europe, Canada, and Australia. In August 2014, the company enrolled 50 individuals for its HeartMate PHP CE Mark trial at sites in Europe and South America.
According to the report, one of the major key drivers for market growth will be to focus on unmet needs for advanced heart failure. The unmet medical needs of the market present significant opportunities for new and emerging vendors to launch new products and expand their businesses. Many available VADs can cause infections and bleeding, affecting the quality of life. This results in poor patient compliance and leads to low survival rates. In addition, these devices have been unsuccessful in significantly improving the treatment options for advanced heart failure. Vendors also need to...
Technavio recognizes the following companies as the key players in the global ventricular assist devices (VADs) market: ABIOMED, Berlin Heart, HeartWare, and St. Jude Medical.
Other Prominent Vendors in the market are: CardiacAssist Technologies, CORWAVE, EVAHEART, Jarvik Heart, Leviticus Cardio, ReliantHeart, Sunshine Heart, and Ventracor.
Browse full report with TOC@ https://marketreportscenter.com/reports/383352/global-ventricular-assist-devices-market-2016-2020
Commenting on the report, an analyst from Technavios team said: Focusing on evidence-based research will be a key trend for market growth. Vendors are collaborating with researchers, academics, and research institutes to obtain sufficient clinical evidence data for the approval and commercialization of their products. Vendors also initiate clinical trials and research activities of their pipeline products to obtain their efficacy and safety profile. For instance, Thoratec is enrolling people for the HeartMate III US clinical trial. In December 2014, the company enrolled 50 individuals under the HeartMate III CE Mark trial at 10 sites across Europe, Canada, and Australia. In August 2014, the company enrolled 50 individuals for its HeartMate PHP CE Mark trial at sites in Europe and South America.
According to the report, one of the major key drivers for market growth will be to focus on unmet needs for advanced heart failure. The unmet medical needs of the market present significant opportunities for new and emerging vendors to launch new products and expand their businesses. Many available VADs can cause infections and bleeding, affecting the quality of life. This results in poor patient compliance and leads to low survival rates. In addition, these devices have been unsuccessful in significantly improving the treatment options for advanced heart failure. Vendors also need to...